Vol 71, No 6 (2020)
Clinical vignette
Published online: 2020-09-25
Endoscopic ultrasound-guided ethanol ablation of insulinoma
1
, 1, 2, 3, 1
, 1, 2, 3, 1
Abstract
Not required for Clinical Vignette.
Keywords: insulinomaethanol ablationhypoglycemia
References
- Buicko JL, Finnerty BM, Zhang T, et al. Insights into the biology and treatment strategies of pancreatic neuroendocrine tumors. Ann Pancreat Cancer. 2019; 2.
- Kos-Kudła B, Blicharz-Dorniak J, Strzelczyk J, et al. Consensus Conference, olish Network of Neuroendocrine Tumours. Pancreatic neuroendocrine neoplasms - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours). Endokrynol Pol. 2013; 64(6): 459–479.
- Barthet M, Giovannini M, Lesavre N, et al. Endoscopic ultrasound-guided radiofrequency ablation for pancreatic neuroendocrine tumors and pancreatic cystic neoplasms: a prospective multicenter study. Endoscopy. 2019; 51(9): 836–842.
- Mele C, Brunani A, Damascelli B, et al. Non-surgical ablative therapies for inoperable benign insulinoma. J Endocrinol Invest. 2018; 41(2): 153–162.
- Dąbkowski K, Gajewska P, Walter K, et al. Successful EUS-guided ethanol ablation of insulinoma, four-year follow-up. Case report and literature review. Endokrynol Pol. 2017; 68(4): 472–479.
